ArticleBMC pulmonary medicine2026
Optimal suction pressure on digital drainage systems for the management of postoperative air leaks together with IL-2 therapy: a retrospective cohort study.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [Digital Drainage Systems in Postoperative Chest Tube Management after Pulmonary Resection: Current Status and Future Perspectives].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
introductionPostoperative pulmonary air leaks is one of the most significant complications, which prolongs hospitalization and increases mortality. The sclerosant interleukin-2 (IL-2) has been widely used in China to reduce postoperative air leaks. However, the optimal suction pressure on digital drainage systems when combined with IL-2 treatment remains elusive among thoracic surgeons. This study aimed to determine the optimal suction pressure provided by digital drainage system, together with IL-2 therapy, for effectively sealing air leaks, and to identify the key factors influencing the healing of air leakage.
methodsA retrospective analysis involving 94 patients was conducted. The collected information included patient demographics, IL-2 treatment regimens, the average suction pressure applied during the IL-2 therapy period, and air leak duration. The suction pressures were categorized into low (1 ≤ pressure < 5 cmH
resultsThe analysis revealed that suction pressure was a statistically significant determinant of air leak duration (P = 0.036). In multivariate analysis, high suction pressure was independently associated with a longer air leak time by approximately 2.84 days (95% CI: -5.16, -0.52, P = 0.017) and 2.21 days (95% CI: -4.08, -0.35, P = 0.021) compared to low and medium pressure, respectively. Subgroup analysis showed no significant interaction between suction pressure and patient/surgical characteristics, indicating the benefit of lower suction was consistent across the cohort. The number of IL-2 treatments was also a strong predictor of air leak duration (P < 0.001), reflecting the need for repeated therapy in persistent leaks.
conclusionsPatients receiving IL-2 therapy benefited more from mild suction pressures (low or medium) compared to high suction pressure, resulting in shorter air leak durations across a range of patient and surgical characteristics. These findings support the use of low-to-medium suction (1-9 cmH₂O) as part of the standard management protocol when IL-2 pleurodesis is employed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.